ArticleSeminars in ophthalmology2021
Emerging therapies for amblyopia.
Article in Seminars in ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07226141 (Valproate for the Treatment of Residual Amblyopia), which is not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Valproate for the Treatment of Residual Amblyopia
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.
- Interventions for improving adherence to amblyopia treatments in children.The Cochrane database of systematic reviews · 2025Pooled it
- Brazilian best practice guidelines for amblyopia diagnosis and management.Arquivos brasileiros de oftalmologia · 2024Guideline
- Comparison of compliance among patients with pediatric amblyopia undergoing virtual reality-based and traditional patching method training.Frontiers in public health · 2022Trial
- Amblyopia and adult health: a comprehensive analysis of long-term systemic, sensory and mental health comorbidities in a national cohort.The British journal of ophthalmology · 2026Article
- Intact Perceptual Interactions of Interocular Temporal Phase and Contrast Disparities in Amblyopia.Investigative ophthalmology & visual science · 2025Article
- Evolving Strategies in Amblyopia Management: From Traditional Therapies to Cutting-Edge Innovations.Cureus · 2025Review
- Visual electrophysiological assessment of children with poor response to treatment for functional amblyopia.International journal of ophthalmology · 2025Article
- Current Developments in the Management of Amblyopia with the Use of Perceptual Learning Techniques.Medicina (Kaunas, Lithuania) · 2023Review
- Factors affecting the benefit of glasses alone in treating childhood amblyopia: an analysis of PEDIG data.BMC ophthalmology · 2023Article
- Amblyopia Treatment through Immersive Virtual Reality: A Preliminary Experience in Anisometropic Children.Vision (Basel, Switzerland) · 2023Article
- Applications and implications for extended reality to improve binocular vision and stereopsis.Journal of vision · 2023Article
- Article
- Metaplasticity: a key to visual recovery from amblyopia in adulthood?Current opinion in ophthalmology · 2022Review
- Article
- Childhood amblyopia: A systematic review of recent management options.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological SocietyArticle
- Treatment Outcome of Occlusion for Unilateral Amblyopia in Saudi Children 6-12 Years Old.Middle East African journal of ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
Abstract
Traditional therapies to treat amblyopia, such as optical correction or occlusion/penalization of the non-amblyopic eye, are efficacious but are not without limitations such as poor adherence and decreased success with increasing age. Recently, there has been an interest in new amblyopia therapies, some using binocular techniques, through a variety of platforms including video games, movies, and virtual reality. Overall, available efficacy results for these treatments are highly variable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.